Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

2.0%

2 terminated/withdrawn out of 100 trials

Success Rate

88.9%

+2.4% vs industry average

Late-Stage Pipeline

37%

37 trials in Phase 3/4

Results Transparency

0%

0 of 16 completed trials have results

Key Signals

29 recruiting

Enrollment Performance

Analytics

Phase 3
27(36.5%)
N/A
19(25.7%)
Phase 2
17(23.0%)
Phase 4
10(13.5%)
Phase 1
1(1.4%)
74Total
Phase 3(27)
N/A(19)
Phase 2(17)
Phase 4(10)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (100)

Showing 20 of 100 trials
NCT07636096Completed

Breast Phyllodes Tumors: Based on 20-year Real-world Data From China

Role: collaborator

NCT07625436Not ApplicableNot Yet Recruiting

Artificial Intelligence for Rare Disease Diagnosis

Role: collaborator

NCT05129904Active Not Recruiting

Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study)

Role: collaborator

NCT03387774Phase 3Completed

Efficacy of Ulinastatin for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients

Role: collaborator

NCT05524168Phase 2Active Not Recruiting

SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal Carcinoma

Role: collaborator

NCT05491811Phase 2Active Not Recruiting

Ensartinib in Combination With Bevacizumab in ALK-positive NSCLC Patients With TP53 Mutation

Role: collaborator

NCT02633202Phase 3Completed

Concurrent Chemotherapy for the Intermediate Risk Nasopharyngeal Carcinoma In Intensity-modulated Radiotherapy Era

Role: collaborator

NCT06140992Recruiting

PaCIFiC-CUP Classifies Cancer of Unknown Primary

Role: collaborator

NCT07539792Phase 2Recruiting

Efficacy and Safety Evaluation of Absorbable and Moldable Skull Base Support Plates in Extended Endoscopic Endonasal Transsphenoidal Surgery: A Prospective, Randomized, Controlled Study

Role: collaborator

NCT07525804Not ApplicableCompleted

Flipped-Discharge Education for PTCD-Managed Malignant Obstructive Jaundice

Role: lead

NCT07425145Not ApplicableNot Yet Recruiting

Transcutaneous Electrical Acustimulation for IBS-D: A Multicenter Study

Role: lead

NCT05198609Phase 3Active Not Recruiting

Camrelizumab, Apatinib Plus HAIC Versus Camrelizumab and Apatinib for HCC With Portal Vein Invasion: a Randomized Trial

Role: collaborator

NCT06783049Not ApplicableRecruiting

Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack With an Intelligent Management System

Role: collaborator

NCT07353749Phase 4Not Yet Recruiting

Efficacy and Safety of Methylprednisolone After Flow-Diverter Stent Implantation in Unruptured Intracranial Aneurysms

Role: collaborator

NCT06518655Recruiting

Differentiation of Benign and Malignant Pulmonary Nodules by Volatile Organic Compounds in Human Exhaled Breath

Role: collaborator

NCT04695925Phase 3Active Not Recruiting

Osimertinib Monotherapy or Combination With Chemotherapy for Advanced NSCLC Concurrent EGFR and TP53 Mutations

Role: collaborator

NCT01471808Phase 4Completed

Effects of Different Early Intensive Therapies on Long-term β-cell Function

Role: collaborator

NCT06241612Phase 3Recruiting

Individualized Elective Neck Irradiation in NPC Patients

Role: collaborator

NCT04384627Phase 3Active Not Recruiting

Reducing Target Volumes in NPC Treated With Induction Chemotherapy Followed by Concurrent Chemoradiotherapy

Role: collaborator

NCT07096219Enrolling By Invitation

Catheter Ablation for Functional Mitral Regurgitation in Persistent Atrial Fibrillation: Development and Validation of a Predictive Model-A Multicenter Prospective Cohort Study

Role: collaborator